AEON Biopharma, Inc. (AEON) vs GT Biopharma, Inc. (GTBP)
AEON Biopharma, Inc. and GT Biopharma, Inc. are both Biotechnology companies. AEON Biopharma, Inc. and GT Biopharma, Inc. are of similar size ($12.7M and $12.3M). Across the 7 metrics below, AEON Biopharma, Inc. leads on 4 and GT Biopharma, Inc. on 3.
Valuation
Profitability
| Metric | AEON | GTBP | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 41.67% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 350.00% | 102.03% | (57.72%) |
| Return on assets | (621.70%) | (176.27%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack